Matinas BioPharma Holdings MTNB
NYSE MTNB
$0.19 +0.01 (+3.34%)
As of: Aug 21, 2026 · 11:19 AM EDT

Matinas BioPharma Holdings (MTNB) Operating Margin Growth (3y) (2018 - 2022)

Matinas BioPharma Holdings (MTNB) Operating Margin Growth (3y) (2018 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.97 Bn 132.12 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.64 Bn 78.64 Bn 3.93 Bn -204.00
3 Argenx Se 65.55 Bn 60.37 Bn 1.37 Bn -537.00
4 Moderna 61.26 Bn 56.12 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.30 Bn 37.20 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.66 Bn 28.35 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.68 Bn 10.29 Bn 668.28 Mn -11,254.00
8 Insmed 27.54 Bn 26.38 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.26 Bn 26.42 Bn - -2,649.00
10 Matinas BioPharma Holdings 1.21 Mn 397,207.65 - -

Historic Data

Download Data
DateValue
Jun 30, 2022 447,611.00
Mar 31, 2021 -529,478.00
Dec 31, 2020 2.06 Mn
Sep 30, 2020 174,155.00
Jun 30, 2018 -67,192.00
Mar 31, 2018 -930,812.00